Article
[Non invasive fetal RhD genotyping using maternal blood: time for use in all RhD negative pregnant women].
Gynecologie, obstetrique & fertilite - 1 Feb 2008
Carbonne B, Cortey A, Rouillac-Le Sciellour C, Brossard Y
Abstract excerpt
Non invasive fetal RhD genotyping, based on polymerase-chain-reaction (PCR), is an accurate and validated technique. It allows a reduction by one-third of anti-D immunoglobulin injections to prevent RhD allo-immunization. In case of maternal anti-D immunization, fetal RhD genotyping allows to focus on RhD positive fetuses only the biologic and sonographic follow-up. The wide use of this technique implies the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
